ChampionX (CHX) Expected to Announce Earnings on Wednesday

ChampionX (NASDAQ:CHX - Get Free Report) will likely be releasing its Q2 2025 earnings data before the market opens on Wednesday, July 23rd. Analysts expect ChampionX to post earnings of $0.44 per share and revenue of $876.63 million for the quarter.

ChampionX (NASDAQ:CHX - Get Free Report) last issued its quarterly earnings data on Tuesday, April 29th. The company reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.41 by $0.09. The business had revenue of $864.46 million during the quarter, compared to the consensus estimate of $900.59 million. ChampionX had a return on equity of 19.25% and a net margin of 8.20%. The business's revenue was down 6.3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.50 earnings per share.

ChampionX Price Performance

CHX remained flat at $25.81 during trading on Thursday. The company's stock had a trading volume of 1,273 shares, compared to its average volume of 2,855,019. The stock has a market cap of $4.94 billion, a price-to-earnings ratio of 17.09, a price-to-earnings-growth ratio of 5.04 and a beta of 1.49. The company has a quick ratio of 1.62, a current ratio of 2.25 and a debt-to-equity ratio of 0.31. ChampionX has a 12-month low of $21.92 and a 12-month high of $35.94. The stock has a fifty day simple moving average of $25.55 and a 200 day simple moving average of $27.06.

ChampionX Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Thursday, July 3rd will be given a $0.095 dividend. The ex-dividend date is Thursday, July 3rd. This represents a $0.38 dividend on an annualized basis and a yield of 1.47%. ChampionX's dividend payout ratio (DPR) is 25.17%.

Analyst Upgrades and Downgrades

Separately, Stifel Nicolaus upped their price objective on shares of ChampionX from $39.00 to $40.00 and gave the stock a "buy" rating in a report on Monday, May 5th.

Institutional Investors Weigh In On ChampionX

A number of hedge funds have recently bought and sold shares of the company. Goldman Sachs Group Inc. raised its position in ChampionX by 6.7% in the first quarter. Goldman Sachs Group Inc. now owns 2,481,246 shares of the company's stock worth $73,941,000 after purchasing an additional 155,819 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in ChampionX by 5.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 432,311 shares of the company's stock worth $12,883,000 after buying an additional 20,756 shares during the last quarter. Baird Financial Group Inc. bought a new stake in ChampionX during the first quarter worth about $214,000. Finally, Geneos Wealth Management Inc. grew its stake in ChampionX by 408.5% during the first quarter. Geneos Wealth Management Inc. now owns 1,683 shares of the company's stock worth $50,000 after buying an additional 1,352 shares during the last quarter. 98.99% of the stock is currently owned by institutional investors.

About ChampionX

ChampionX Corporation provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide. The company operates through four segments: Production Chemical Technologies, Production & Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies.